Repligen | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Agilent USD 1.31B 12M 2025-01
Align Technology USD 851.07M 35.5M 2024-12
Bio Techne USD 249.61M 141K 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Bruker USD 915.5M 119.2M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Danaher USD 5.11B 273M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
General Electric USD 8.72B 10.15B 2024-12
Henry Schein USD 3.04B 19M 2024-12
Illumina USD 929M 590M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Patterson Companies USD 1.53B 109.77M 2025-01
Pfizer USD 18.17B 5.63B 2024-12
Repligen USD 162.7M 10.11M 2024-09
Revvity USD 610.62M 24.72M 2024-12
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Waters USD 580.45M 51.28M 2024-12
West Pharmaceutical Services USD 589.2M 3.6M 2024-12



Repligen Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.